The global Blood-Grouping Reagents Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Technique (PCRbased and microarray techniques, Assaybased techniques, Massively parallel sequencing techniques, Serology ), By End-User (Hospitals and blood banks, Clinical laboratories, Academic and research institutes).
The Blood-Grouping Reagents Market focuses on reagents, antibodies, and laboratory solutions used in blood typing, blood compatibility testing, and transfusion medicine to determine ABO blood groups, Rh factor, and other blood group antigens. In 2025, blood-grouping reagents include monoclonal antibodies, antisera, and blood typing kits that facilitate safe and accurate blood transfusions, donor selection, and blood bank operations in healthcare facilities. With considerations for blood product compatibility, transfusion reactions prevention, and serological testing, the blood-grouping reagents market supports blood banking, immunohematology, and transfusion safety practices.
The global Blood-Grouping Reagents Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Blood-Grouping Reagents Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Blood-Grouping Reagents Industry include- Arena Bio Scien, Atlas Medical GmbH, AXO Science, BAG Diagnostics GmbH, Bio Rad Laboratories Inc, Calibre Scientific Inc, Danaher Corp, DIAGAST SAS, Grifols SA, Haemokinesis Ltd, Merck KGaA, Mesa Laboratories Inc, Novacyt SA, QuidelOrtho Corp, Quotient Ltd, Rapid Labs Ltd, Torax Biosciences Ltd, Tulip Diagnostics Pvt. Ltd, Werfenlife SA.
A prominent trend in the Blood Grouping Reagents market is the advancements in immunohematology and transfusion medicine, including the development of novel blood typing technologies, extended antigen testing panels, and compatibility testing methods, to improve blood bank operations, enhance blood product safety, and expand donor compatibility testing capabilities. With increasing demand for blood products, growing regulatory scrutiny, and evolving transfusion practices, there is a shift towards innovative blood grouping reagents that offer enhanced specificity, sensitivity, and reliability in antigen typing, antibody screening, and crossmatching procedures, driving market demand and investment in next-generation blood banking technologies.
A significant driver for the Blood Grouping Reagents market is the increasing blood transfusion requirements worldwide, driven by factors such as rising surgical volumes, trauma cases, and chronic disease prevalence, coupled with the growing diversity of blood donors and recipient populations. As blood banks and transfusion services strive to meet the diverse clinical needs of patients, ensure blood product safety, and minimize transfusion-related complications, there is a growing demand for blood grouping reagents that can accurately and efficiently match donor blood with recipient blood, identify compatible blood products, and prevent adverse transfusion reactions, driving market demand and investment in blood typing and compatibility testing solutions.
An opportunity for market differentiation and product innovation in the Blood Grouping Reagents market lies in developing customized reagent panels and automated testing systems that streamline blood typing workflows, improve laboratory efficiency, and optimize resource utilization in blood bank operations. By offering modular reagent kits, multiplexed testing platforms, and integrated automation solutions, blood grouping reagent manufacturers and laboratory equipment suppliers can address the diverse needs of transfusion centers, hospitals, and blood collection facilities, while enhancing testing accuracy, reducing turnaround times, and ensuring compliance with regulatory requirements, thereby creating new opportunities for market expansion, customer engagement, and value-added services in the dynamic field of immunohematology and blood transfusion medicine.
Assay-based techniques for blood grouping reagents emerge as the fastest-growing segment in this market. These techniques utilize advanced assay methodologies to accurately determine blood groups and antigens, offering higher sensitivity and specificity compared to traditional serological methods. Assay-based techniques often involve the use of specific antibodies or antigens that react with blood components, allowing for precise identification of blood groups and compatibility testing for transfusions. These techniques also provide rapid results, reducing turnaround times in blood bank and clinical laboratory settings. Moreover, assay-based approaches are increasingly favored for their automation capabilities, enabling high-throughput screening and analysis, which is particularly beneficial for hospitals, blood banks, and clinical laboratories dealing with large volumes of blood samples. As a result, the adoption of assay-based techniques is rapidly increasing across various end-user segments, driving the overall growth of the blood grouping reagents market.
By Technique
By End-User
Geographical Analysis
* List not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Blood-Grouping Reagents Market, encompassing current market size, growth trends, and forecasts till 2034.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Blood-Grouping Reagents Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Blood-Grouping Reagents Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Blood-Grouping Reagents Market Size Outlook, $ Million, 2021 to 2030
3.2 Blood-Grouping Reagents Market Outlook by Type, $ Million, 2021 to 2030
3.3 Blood-Grouping Reagents Market Outlook by Product, $ Million, 2021 to 2030
3.4 Blood-Grouping Reagents Market Outlook by Application, $ Million, 2021 to 2030
3.5 Blood-Grouping Reagents Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Blood-Grouping Reagents Industry
4.2 Key Market Trends in Blood-Grouping Reagents Industry
4.3 Potential Opportunities in Blood-Grouping Reagents Industry
4.4 Key Challenges in Blood-Grouping Reagents Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Blood-Grouping Reagents Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Blood-Grouping Reagents Market Outlook by Segments
7.1 Blood-Grouping Reagents Market Outlook by Segments, $ Million, 2021- 2030
By Technique
PCRbased and microarray techniques
Assaybased techniques
Massively parallel sequencing techniques
Serology
By End-User
Hospitals and blood banks
Clinical laboratories
Academic and research institutes
8 North America Blood-Grouping Reagents Market Analysis and Outlook To 2030
8.1 Introduction to North America Blood-Grouping Reagents Markets in 2024
8.2 North America Blood-Grouping Reagents Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Blood-Grouping Reagents Market size Outlook by Segments, 2021-2030
By Technique
PCRbased and microarray techniques
Assaybased techniques
Massively parallel sequencing techniques
Serology
By End-User
Hospitals and blood banks
Clinical laboratories
Academic and research institutes
9 Europe Blood-Grouping Reagents Market Analysis and Outlook To 2030
9.1 Introduction to Europe Blood-Grouping Reagents Markets in 2024
9.2 Europe Blood-Grouping Reagents Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Blood-Grouping Reagents Market Size Outlook by Segments, 2021-2030
By Technique
PCRbased and microarray techniques
Assaybased techniques
Massively parallel sequencing techniques
Serology
By End-User
Hospitals and blood banks
Clinical laboratories
Academic and research institutes
10 Asia Pacific Blood-Grouping Reagents Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Blood-Grouping Reagents Markets in 2024
10.2 Asia Pacific Blood-Grouping Reagents Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Blood-Grouping Reagents Market size Outlook by Segments, 2021-2030
By Technique
PCRbased and microarray techniques
Assaybased techniques
Massively parallel sequencing techniques
Serology
By End-User
Hospitals and blood banks
Clinical laboratories
Academic and research institutes
11 South America Blood-Grouping Reagents Market Analysis and Outlook To 2030
11.1 Introduction to South America Blood-Grouping Reagents Markets in 2024
11.2 South America Blood-Grouping Reagents Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Blood-Grouping Reagents Market size Outlook by Segments, 2021-2030
By Technique
PCRbased and microarray techniques
Assaybased techniques
Massively parallel sequencing techniques
Serology
By End-User
Hospitals and blood banks
Clinical laboratories
Academic and research institutes
12 Middle East and Africa Blood-Grouping Reagents Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Blood-Grouping Reagents Markets in 2024
12.2 Middle East and Africa Blood-Grouping Reagents Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Blood-Grouping Reagents Market size Outlook by Segments, 2021-2030
By Technique
PCRbased and microarray techniques
Assaybased techniques
Massively parallel sequencing techniques
Serology
By End-User
Hospitals and blood banks
Clinical laboratories
Academic and research institutes
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Arena Bio Scien
Atlas Medical GmbH
AXO Science
BAG Diagnostics GmbH
Bio Rad Laboratories Inc
Calibre Scientific Inc
Danaher Corp
DIAGAST SAS
Grifols SA
Haemokinesis Ltd
Merck KGaA
Mesa Laboratories Inc
Novacyt SA
QuidelOrtho Corp
Quotient Ltd
Rapid Labs Ltd
Torax Biosciences Ltd
Tulip Diagnostics Pvt. Ltd
Werfenlife SA
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Technique
PCRbased and microarray techniques
Assaybased techniques
Massively parallel sequencing techniques
Serology
By End-User
Hospitals and blood banks
Clinical laboratories
Academic and research institutes
The Global Blood-Grouping Reagents Market Size is estimated at $2.4 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 8.6% to reach $5 Billion by 2034.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Arena Bio Scien, Atlas Medical GmbH, AXO Science, BAG Diagnostics GmbH, Bio Rad Laboratories Inc, Calibre Scientific Inc, Danaher Corp, DIAGAST SAS, Grifols SA, Haemokinesis Ltd, Merck KGaA, Mesa Laboratories Inc, Novacyt SA, QuidelOrtho Corp, Quotient Ltd, Rapid Labs Ltd, Torax Biosciences Ltd, Tulip Diagnostics Pvt. Ltd, Werfenlife SA
Base Year- 2024; Estimated Year- 2025; Historic Period- 2019-2024; Forecast period- 2025 to 2034; Currency: Revenue (USD); Volume